Article info

Download PDFPDF
Inhaled corticosteroids in COPD: quantifying risks and benefits
  1. Correspondence to Dr Chris Cates, PHSE, SGUL, Cranmer Terrace, London SW17 0RE, UK; ccates{at}sgul.ac.uk
View Full Text

Citation

Cates C
Inhaled corticosteroids in COPD: quantifying risks and benefits

Publication history

  • First published December 15, 2012.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.